Dr. Steven Feldman, MD, PhD
Claim this profileWake Forest University Health Sciences Department of Dermatology
Studies Plaque Psoriasis
Studies Psoriasis
10 reported clinical trials
20 drugs studied
Affiliated Hospitals
Clinical Trials Steven Feldman, MD, PhD is currently running
Text Reminders
for Psoriasis Treatment Adherence
Psoriasis patients are very poorly adherent to topical treatment. If adherence issues are ignored, poor adherence may limit the real-world efficacy of deucravacitinib, too. Forty psoriasis patients recruited from Wake Forest Baptist Health Dermatology Clinic will be enrolled. Twenty will be randomized to a reporting intervention designed to promote better adherence and the remaining 20 patients will serve as controls who will not receive a reporting intervention. Through qualitative interviews of the 40 patients recruited, we plan to study the behaviors of the most adherent patients to better understand specific beliefs and behaviors of adherent patients and to identify practical, modifiable factors that can improve adherence. We will also compare treatment outcomes and efficacy of deucravacitinib between the most and least adherence patients.
Recruiting1 award N/A5 criteria
Topical Treatment
for Eczema
Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.
Recruiting1 award N/A
More about Steven Feldman, MD, PhD
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Steven Feldman, MD, PhD has experience with
- Betamethasone Dipropionate 0.05% Cream
- Tapinarof
- Normal Education Material
- Vignette
- Transcutaneous Electrical Nerve Stimulation (TENS) Therapy
- Triamcinolone Cream
Breakdown of trials Steven Feldman, MD, PhD has run
Plaque Psoriasis
Psoriasis
Eczema
Vasculopathic Skin Disease
Pigment Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Steven Feldman, MD, PhD specialize in?
Is Steven Feldman, MD, PhD currently recruiting for clinical trials?
Are there any treatments that Steven Feldman, MD, PhD has studied deeply?
What is the best way to schedule an appointment with Steven Feldman, MD, PhD?
What is the office address of Steven Feldman, MD, PhD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.